|
ELAN-ONCOVAL (Elderly Head and Neck Cancer-Oncology Evaluation) study: Evaluation of the G8 screening tool and the ELAN geriatric evaluation (EGE) for elderly patients (pts) with head and neck squamous cell carcinomas (HNSCC). |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Innate Pharma; Merck Serono; MSD |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Serono |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Merck |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD |
|
|
Consulting or Advisory Role - Bayer; Sanofi (Inst) |
Speakers' Bureau - Leo Pharma |
Travel, Accommodations, Expenses - Bayer; Leo Pharma; Pfizer |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; Pfizer |
|
|
Honoraria - AstraZeneca; Biogen; Bristol-Myers Squibb; Innate Pharma; Merck Serono; Merck Sharp & Dohme |
Consulting or Advisory Role - AstraZeneca; BIOGEN; Bristol-Myers Squibb; Innate Pharma; Merck Serono; Merck Sharp & Dohme |
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Nutricia; Pierre Fabre; Roche; Servier |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Novartis; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Innate Pharma; Merck Serono |
Research Funding - Bristol-Myers Squibb (Inst); MERCK SERONO (Inst) |